{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:58:26Z","timestamp":1788188306840,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["2015M3C8A6A06014500"],"award-info":[{"award-number":["2015M3C8A6A06014500"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["2015R1A2A2A04003620"],"award-info":[{"award-number":["2015R1A2A2A04003620"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.bbrc.2016.01.022","type":"journal-article","created":{"date-parts":[[2016,1,6]],"date-time":"2016-01-06T05:06:18Z","timestamp":1452056778000},"page":"748-752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Trichostatin A enhances estrogen receptor-alpha repression in MCF-7 breast cancer cells under hypoxia"],"prefix":"10.1016","volume":"470","author":[{"given":"Hyunggyun","family":"Noh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joonwoo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myeongguk","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7835-1546","authenticated-orcid":false,"given":"YoungJoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2016.01.022_bib1","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJM199810013391407","article-title":"Treatment of breast cancer","volume":"339","author":"Hortobagyi","year":"1998","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2016.01.022_bib2","doi-asserted-by":"crossref","first-page":"E4600","DOI":"10.1073\/pnas.1513433112","article-title":"Chemotherapy triggers HIF-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype","volume":"112","author":"Lu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2016.01.022_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/bbrc.2001.4339","article-title":"MDM2 enhances the function of estrogen receptor alpha in human breast cancer cells","volume":"281","author":"Saji","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2016.01.022_bib4","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1073\/pnas.0610887104","article-title":"Estrogen receptor alpha is a putative substrate for the BRCA1 ubiquitin ligase","volume":"104","author":"Eakin","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2016.01.022_bib5","article-title":"A\u00a0pooled analysis of post-diagnosis lifestyle factors in association with late estrogen-receptor positive breast cancer prognosis","author":"Nechuta","year":"2015","journal-title":"Int. J. Cancer. J. Int. du cancer"},{"key":"10.1016\/j.bbrc.2016.01.022_bib6","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.284.5418.1354","article-title":"BRCA1 inhibition of estrogen receptor signaling in transfected cells","volume":"284","author":"Fan","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2016.01.022_bib7","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.bcp.2004.05.037","article-title":"Acetylation of nuclear receptors in cellular growth and apoptosis","volume":"68","author":"Fu","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2016.01.022_bib8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1677\/erc.1.00728","article-title":"Hypoxia-inducible factor-1 in human breast and prostate cancer","volume":"13","author":"Kimbro","year":"2006","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbrc.2016.01.022_bib9","doi-asserted-by":"crossref","first-page":"E5429","DOI":"10.1073\/pnas.1421438111","article-title":"Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells","volume":"111","author":"Samanta","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2016.01.022_bib10","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1349-7006.2001.tb01064.x","article-title":"Hypoxia reduces hormone responsiveness of human breast cancer cells","volume":"92","author":"Kurebayashi","year":"2001","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.bbrc.2016.01.022_bib11","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1210\/me.2004-0162","article-title":"Cobalt chloride-induced estrogen receptor alpha down-regulation involves hypoxia-inducible factor-1alpha in MCF-7 human breast cancer cells","volume":"19","author":"Cho","year":"2005","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbrc.2016.01.022_bib12","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.bbrc.2011.03.119","article-title":"Hypoxia-inducible factor 1 alpha represses the transcription of the estrogen receptor alpha gene in human breast cancer cells","volume":"407","author":"Ryu","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2016.01.022_bib13","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1038\/onc.2011.483","article-title":"Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-alpha","volume":"31","author":"Vesuna","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2016.01.022_bib14","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/mc.21875","article-title":"Curcumin enhances the anticancer effects of trichostatin A in breast cancer cells","volume":"52","author":"Yan","year":"2013","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bbrc.2016.01.022_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1172\/JCI69738","article-title":"New and emerging HDAC inhibitors for cancer treatment","volume":"124","author":"West","year":"2014","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.bbrc.2016.01.022_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13148-010-0012-4","article-title":"Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy","volume":"1","author":"Wagner","year":"2010","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.bbrc.2016.01.022_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1476-4598-12-9","article-title":"Epigenetic reactivation of estrogen receptor-alpha (ERalpha) by genistein enhances hormonal therapy sensitivity in ERalpha-negative breast cancer","volume":"12","author":"Li","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2016.01.022_bib18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.bbrc.2015.09.182","article-title":"Trichostatin A and Tamoxifen inhibit breast cancer cell growth by miR-204 and ERalpha reducing AKT\/mTOR pathway","volume":"467","author":"Liu","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2016.01.022_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jgr.2014.09.001","article-title":"Korean Red Ginseng attenuates ethanol-induced steatosis and oxidative stress via AMPK\/Sirt1 activation","volume":"39","author":"Han","year":"2015","journal-title":"J.\u00a0Ginseng Res."},{"key":"10.1016\/j.bbrc.2016.01.022_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10549-014-3233-y","article-title":"HDAC inhibition does not induce estrogen receptor in human triple-negative breast cancer cell lines and patient-derived xenografts","volume":"149","author":"de Cremoux","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbrc.2016.01.022_bib21","first-page":"6890","article-title":"Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition","volume":"60","author":"Yang","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2016.01.022_bib22","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1038\/sj.onc.1207315","article-title":"The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen","volume":"23","author":"Jang","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2016.01.022_bib23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0303-7207(97)00235-9","article-title":"Estrogen receptor down-regulation is regulated noncooperatively by estrogen at the transcription level","volume":"137","author":"Lee","year":"1998","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbrc.2016.01.022_bib24","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1677\/erc.1.00846","article-title":"Pure oestrogen antagonists for the treatment of advanced breast cancer","volume":"13","author":"Howell","year":"2006","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbrc.2016.01.022_bib25","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1097-2765(00)80259-2","article-title":"The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation","volume":"5","author":"Lonard","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2016.01.022_bib26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jsbmb.2006.03.002","article-title":"Hypoxic activation of unoccupied estrogen-receptor-alpha is mediated by hypoxia-inducible factor-1 alpha","volume":"100","author":"Cho","year":"2006","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbrc.2016.01.022_bib27","first-page":"971","article-title":"Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in\u00a0vivo","volume":"7","author":"Vigushin","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2016.01.022_bib28","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1038\/sj.onc.1208662","article-title":"Multiple mechanisms induce transcriptional silencing of a subset of genes, including oestrogen receptor alpha, in response to deacetylase inhibition by valproic acid and trichostatin A","volume":"24","author":"Reid","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2016.01.022_bib29","doi-asserted-by":"crossref","first-page":"8094","DOI":"10.1158\/1078-0432.CCR-04-1023","article-title":"Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines","volume":"10","author":"Alao","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2016.01.022_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11010-012-1288-9","article-title":"The enhanced antiproliferative response to combined treatment of trichostatin A with raloxifene in MCF-7 breast cancer cells and its relevance to estrogen receptor beta expression","volume":"366","author":"Tu","year":"2012","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbrc.2016.01.022_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10549-007-9751-0","article-title":"Trichostatin A and 5 Aza-2' deoxycytidine decrease estrogen receptor mRNA stability in ER positive MCF7 cells through modulation of HuR","volume":"111","author":"Pryzbylkowski","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbrc.2016.01.022_bib32","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1210\/me.2004-0011","article-title":"Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells","volume":"19","author":"Sharma","year":"2005","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbrc.2016.01.022_bib33","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1677\/jme.0.0320583","article-title":"Histone deacetylase inhibition and estrogen receptor alpha levels modulate the transcriptional activity of partial antiestrogens","volume":"32","author":"Margueron","year":"2004","journal-title":"J.\u00a0Mol. Endocrinol."},{"key":"10.1016\/j.bbrc.2016.01.022_bib34","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.bcp.2007.10.035","article-title":"Histone deacetylase inhibitor SAHA induces ERalpha degradation in breast cancer MCF-7 cells by CHIP-mediated ubiquitin pathway and inhibits survival signaling","volume":"75","author":"Yi","year":"2008","journal-title":"Biochem. Pharmacol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X16300225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X16300225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T21:58:21Z","timestamp":1655330301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X16300225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0006291X16300225"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.01.022","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trichostatin A enhances estrogen receptor-alpha repression in MCF-7 breast cancer cells under hypoxia","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}